IQM Quantum Computers and Real Asset Acquisition Corp. complete the combination; trading in IQM’s ADSs and IQM Warrants on Nasdaq Stock Market LLC commences on July 2, 2026

IQM completed its SPAC merger with Real Asset Acquisition Corp., with consideration paid via 14,381,747 existing IQM shares and ADSs beginning trading on Nasdaq July 2, 2026 under “IQMX”. The deal closed alongside a PIPE, issuing 14,548,000 IQM shares at $10.00 per share for EUR 127.7m (USD 145.5m) gross, bringing total net proceeds to ~EUR 198.7m (USD 233.5m) and including warrant terms with an $11.50 exercise price.

Analysis

The key market implication is not the listing itself but the reset in financing optionality. Public paper plus the PIPE gives the company a longer runway to keep bidding on prestige projects, which tends to matter more in quantum than near-term revenue and can improve its win rate versus private rivals that are still fundraising in a tighter VC market. The flip side is that this also creates a visible valuation anchor: once the market can price a liquid quantum name daily, execution gaps will be punished faster than they were in private markets.

For the public quantum basket, this is modestly sentiment-positive for QUBT and any other pure-play because it validates continued equity sponsorship for the theme, but it also raises the bar on differentiation. The likely second-order effect is a rotation from "quantum as narrative" into "quantum as procurement and installed-base story," which favors firms with repeatable system deliveries and enterprise references over those selling only roadmaps. BNY’s economics are trivial here; the real commercial question is whether the new public currency reduces IQM’s future dilution per contract won.

The risk is classic de-SPAC behavior: the first several weeks can trade on float dynamics and warrant arb rather than fundamentals, especially with a $11.50 strike sitting close to the likely speculative price band. If management does not show a clear bookings/backlog bridge over the next 1-3 quarters, the market will re-anchor to cash burn and forced follow-on financing risk. The thesis would be falsified if the company lands a meaningful government or HPC deployment that converts into multi-year contracted revenue before the market starts pricing another capital raise.

Key Decisions for Investors

• Fade opening-week strength in IQMX only if the stock trades well above PIPE terms and the warrant overhang is active; use a small short or put spread with a 2-6 week horizon, since the trade works only if post-listing enthusiasm decays faster than new buyer demand.
• Avoid chasing BNY on the headline: the depositary fee stream is immaterial and there is no meaningful earnings sensitivity. Treat it as a non-actionable operational event unless there is evidence of a broader ADR issuance pipeline.
• Watch QUBT as the closest public sentiment proxy for quantum beta; if IQMX starts trading at a premium despite no visible revenue inflection, QUBT can carry sympathy upside for 1-4 weeks. Consider a tactical long QUBT only on sector momentum, not on IQM fundamentals.
• Set a 1-3 month alert on IQMX disclosures for backlog, customer concentration, and gross margin trajectory. If cash burn implies another raise inside 18 months, the name should be treated as a financing story, not a commercialization story.
• If borrow is available, consider a pair: short IQMX versus long a broader semicap/compute beneficiary basket rather than a direct quantum hedge, to isolate the valuation risk without taking binary theme exposure.